Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Early Clinical Study to Investigate the Safety, Pharmacokinetics, and Efficacy of PD-1-M1-NK Cells (YC-T-001) in Patients With Advanced Gastric or Colorectal Cancer Failed or Intolerant to at Least Second-line Therapy

NCT07031011 is registered in ClinicalTrials.gov with jiuwei cui as lead sponsor.

NCT NCT07031011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07031011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Early Clinical Study to Investigate the Safety, Pharmacokinetics, and Efficacy of PD-1-M1-NK Cells (YC-T-001) in Patients With Advanced Gastric or Colorectal Cancer Failed or Intolerant to at Least Second-line Therapy
Lead sponsor
jiuwei cui
Phase
Phase 1
Overall status
Not yet recruiting
Start date
June 30, 2025
Completion date
June 30, 2027
Enrollment
22 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced gastric or colorectal cancer